HIV-1–infected mothers are recommended not to breastfeed their infants.
Fostemsavir is a prodrug of temsavir.
Skip to main content
Litt's app available free to subscribers - download for IOS and Android from the App Store or Google Play.
- Trade Name: Rukobia (ViiV)
- Indications: HIV-1 infection
- Synonym: Fostemsavir tromethamine
- Class: Antiretroviral, Antiviral
- Half-life: 11 hours
- FDA Approval Date: 07/02/2020
- Clinically important, potentially hazardous interactions with:
Carbamazepine, CYP3A4 inducers, Enzalutamide, Mitotane, Phenytoin, Rifampin, St John's Wort - Pregnancy: Insufficient human data to adequately assess a drug-associated risk of birth defects and miscarriage.
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
